Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature

doi:10.12998/wjcc.v6.i14.854

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12778)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

456

WORD

290

HTML

9485

Figures (1-6)

655

Sum=10886

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

759

Download

1133

Sum=1892

Nov 26, 2018 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Nov 26, 2018; 6(14): 854-861
Published online Nov 26, 2018. doi: 10.12998/wjcc.v6.i14.854

Full Size Figure Download Figure

Figure 5 Increase in the levels of FT3, FT4, TPOAb, and TgAb and decrease in TSH during the first month after treatment. Thereafter, FT3, FT4, TPOAb, and TgAb declined and TSH levels rose gradually.

Citation: Zhang F, Lin XY, Chen J, Peng SQ, Shan ZY, Teng WP, Yu XH. Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature. World J Clin Cases 2018; 6(14): 854-861
URL: https://www.wjgnet.com/2307-8960/full/v6/i14/854.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i14.854